For patients with hematologic malignancies, 18, 22, and 22 percent have clinically significant depression, anxiety, PTSD at six months
Benefits seen across all patient conditions for pain, stress, and anxiety
For patients with hematologic malignancies, 18, 22, and 22 percent have clinically significant depression, anxiety, PTSD at six months
Benefits seen across all patient conditions for pain, stress, and anxiety